EP4157303A1 - Medicament a base d'un melange d'huiles essentielles de sept(7) plantes medicinales pour le traitement de la covid-19, utilise seul ou en association avec le melange d'extraits de huit (8) autres plantes medicinales - Google Patents
Medicament a base d'un melange d'huiles essentielles de sept(7) plantes medicinales pour le traitement de la covid-19, utilise seul ou en association avec le melange d'extraits de huit (8) autres plantes medicinalesInfo
- Publication number
- EP4157303A1 EP4157303A1 EP21732604.0A EP21732604A EP4157303A1 EP 4157303 A1 EP4157303 A1 EP 4157303A1 EP 21732604 A EP21732604 A EP 21732604A EP 4157303 A1 EP4157303 A1 EP 4157303A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- plants
- essential oils
- treatment
- mixture
- covid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 53
- 238000011282 treatment Methods 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 208000025721 COVID-19 Diseases 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 title claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 96
- 238000000034 method Methods 0.000 claims abstract description 17
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 10
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract description 9
- 244000165082 Lavanda vera Species 0.000 claims abstract description 8
- 241001116389 Aloe Species 0.000 claims abstract description 7
- 206010011224 Cough Diseases 0.000 claims abstract description 7
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 7
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 7
- 206010006451 bronchitis Diseases 0.000 claims abstract description 7
- 201000008827 tuberculosis Diseases 0.000 claims abstract description 7
- 240000005020 Acaciella glauca Species 0.000 claims abstract description 6
- 244000301850 Cupressus sempervirens Species 0.000 claims abstract description 6
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 6
- 208000006673 asthma Diseases 0.000 claims abstract description 6
- 206010022000 influenza Diseases 0.000 claims abstract description 6
- 241000207199 Citrus Species 0.000 claims abstract description 5
- 240000004784 Cymbopogon citratus Species 0.000 claims abstract description 5
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims abstract description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000201282 Limonium Species 0.000 claims abstract description 5
- 235000001136 Melaleuca leucadendron Nutrition 0.000 claims abstract description 5
- 241000498779 Myristica Species 0.000 claims abstract description 5
- 235000008582 Pinus sylvestris Nutrition 0.000 claims abstract description 5
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 5
- 244000237444 Xylopia aethiopica Species 0.000 claims abstract description 5
- 235000011842 Xylopia aethiopica Nutrition 0.000 claims abstract description 5
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 5
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 5
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 5
- 201000003146 cystitis Diseases 0.000 claims abstract description 5
- 235000008397 ginger Nutrition 0.000 claims abstract description 5
- 235000015639 rosmarinus officinalis Nutrition 0.000 claims abstract description 5
- 239000001841 zingiber officinale Substances 0.000 claims abstract description 5
- 240000002234 Allium sativum Species 0.000 claims abstract description 4
- 208000001528 Coronaviridae Infections Diseases 0.000 claims abstract description 4
- 206010018612 Gonorrhoea Diseases 0.000 claims abstract description 4
- 208000025747 Rheumatic disease Diseases 0.000 claims abstract description 4
- 235000004611 garlic Nutrition 0.000 claims abstract description 4
- 239000001839 pinus sylvestris Substances 0.000 claims abstract description 3
- 244000061408 Eugenia caryophyllata Species 0.000 claims abstract 3
- 230000000552 rheumatic effect Effects 0.000 claims abstract 3
- 208000007190 Chlamydia Infections Diseases 0.000 claims abstract 2
- 208000007514 Herpes zoster Diseases 0.000 claims abstract 2
- 235000010701 Lavanda vera Nutrition 0.000 claims abstract 2
- 244000203416 Melaleuca leucadendron Species 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims description 10
- 241000721662 Juniperus Species 0.000 claims description 5
- 229940126601 medicinal product Drugs 0.000 claims description 5
- 230000002485 urinary effect Effects 0.000 claims description 4
- 208000019693 Lung disease Diseases 0.000 claims description 3
- 208000001786 gonorrhea Diseases 0.000 claims description 3
- 230000002685 pulmonary effect Effects 0.000 abstract description 4
- 241000592238 Juniperus communis Species 0.000 abstract description 3
- 206010046901 vaginal discharge Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 17
- 239000000686 essence Substances 0.000 description 16
- 239000000470 constituent Substances 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000002421 anti-septic effect Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000002921 anti-spasmodic effect Effects 0.000 description 6
- 239000000812 cholinergic antagonist Substances 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000001256 steam distillation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000218691 Cupressaceae Species 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 4
- 240000002657 Thymus vulgaris Species 0.000 description 4
- 235000007303 Thymus vulgaris Nutrition 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 238000000222 aromatherapy Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000001102 lavandula vera Substances 0.000 description 4
- 235000018219 lavender Nutrition 0.000 description 4
- 238000002803 maceration Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000001585 thymus vulgaris Substances 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 240000007220 Melaleuca leucadendra Species 0.000 description 3
- 241000378544 Melaleuca quinquenervia Species 0.000 description 3
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- -1 geranyl ethers Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229930003658 monoterpene Natural products 0.000 description 3
- 150000002773 monoterpene derivatives Chemical class 0.000 description 3
- 235000002577 monoterpenes Nutrition 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 238000009160 phytotherapy Methods 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- IAIHUHQCLTYTSF-UHFFFAOYSA-N 2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1CC2(C)C(O)C(C)(C)C1C2 IAIHUHQCLTYTSF-UHFFFAOYSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 241001678559 COVID-19 virus Species 0.000 description 2
- 241000218631 Coniferophyta Species 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 235000002997 Lavandula Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000010692 aromatic oil Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229930006727 (-)-endo-fenchol Natural products 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- JWQKMEKSFPNAIB-SNVBAGLBSA-N (5r)-1-methyl-5-prop-1-en-2-ylcyclohexene Chemical compound CC(=C)[C@@H]1CCC=C(C)C1 JWQKMEKSFPNAIB-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 241000512005 Alstonia Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 241000950448 Annickia chlorantha Species 0.000 description 1
- 235000001839 Bromelia pinguin Nutrition 0.000 description 1
- 244000139184 Canarium schweinfurthii Species 0.000 description 1
- 235000003244 Canarium schweinfurthii Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010061041 Chlamydial infection Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 244000062757 Cryptocarya agathophylla Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 235000017710 Melaleuca viridiflora Nutrition 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000219926 Myrtaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- UXZIDIYMFIBDKT-UHFFFAOYSA-N Sylvestrene Natural products CC(=C)C1CCCC(C)=C1 UXZIDIYMFIBDKT-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 235000012544 Viola sororia Nutrition 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 201000000902 chlamydia Diseases 0.000 description 1
- 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
Definitions
- Medicinal product based on a mixture of ewo 2021/242124 oils of seven (7) medicinal plants for PCT / O A2021 / 000002 of COVID-19, used alone or in combination with the mixture of extracts of eight (8) other medicinal plants
- the present invention relates to a medicament based on herbal essential oils for the treatment of COVID-19 infection, caused by the emerging virus, SARS-CoV-2.
- the medication I am offering is an essential oil blend of seven (7) medicinal plants.
- the peculiarity of the invention lies in the selection of the plants from which the essential oils of the mixture are extracted, in the process of obtaining the medicament and in its use.
- Dr BEGO's treatise presents the substance of essential oils in their therapeutic functions. This 47-page booklet is the foundation for using essential oils. It explains how to choose them well and how to use them for each one.
- drugs are used to develop 50 medicinal preparations by cooking, decoction , expression, infusion, maceration, chewing, kneading, pounding, pulverizing, softening, grating, roasting and trituration.
- the aim of the authors is to present remedies of plant origin, which are effective and which are not toxic. They start from the uses of these plants made by healers, traditional healers and researchers.
- the study of each plant provides all the necessary information that allows anyone to use them for self-care: the scientific name of the plant, its family and synonymous scientific names, the names given in different languages, a description of the characters botanicals. General information on the use and therapeutic properties are given; these properties are confirmed by laboratory studies.
- the main known constituents are indicated, however the authors do not give chemical formulas.
- the uses and dosage tell about the diseases that each plant cures. Finally, there are photo boards that identify plants, this difficult job of identification that often prevents many people from using herbal medicine books.
- the book presents medicinal plants from around the world; the criterion of choice is efficiency.
- the author wants to be complete in terms of information about each medicinal plant chosen. It presents, in great detail, the origin and description of the plant, the therapeutic actions, parts used and the method of preparation, internal and external use, the main constituents and contraindications.
- the author presents the substances of 56 African plants by giving the results of all the analyzes which have been made to date. Starting from the active ingredients, it indicates how each plant can be used either in the medical field or in the economic field. For each plant, the author gives a botanical description and traditional uses. - RIVA, E., L'Universo delle piante medicinali. Tattato storico, botanico di tutto il mondo, ed. Ghedina e Tassotti, 1995.
- Maria Treben is a phytotherapist, and she worked to collect medicinal recipes for this or that pathology, recipes that people used to cure themselves. So she prescribed treatments to people who came to her. She gives the traditional uses of plants and indicates how she herself prescribes the drug to patients, in the form of herbal tea, decoction, tincture, maceration.
- One aspect that attracts a lot of attention in her practice are the examples of the healings she reports.
- Dr Jean Valnet is one of the foremost specialists in herbal medicine. In aromatherapy, he set out to study particularly essential oils, which reveal unimaginable therapeutic powers. The study of each plant is preceded by a good introduction which tries to give phytotherapy its letter of nobility, general considerations concerning the general properties of aromatic essences and observations of clinical cases. For each of the 53 plants studied, the author describes the main constituents, therapeutic properties, internal and external uses, directions for use and other very interesting information. Doctor Jean Valnet is not just a mere theorist; it guides well in the association of different essential oils to overcome pathologies.
- the book provides the substances of the plants we eat; some of these vegetables, fruits and grains are medicinal plants and are used as such. To present them, the author gives the following outline: the main constituents, properties, indications and instructions for use. Among these plants, here is the cabbage which, in history, was a true panacea. Let us read, on this subject, the author of the book: "One could be astonished that this exceptional therapeutic means - known since Antiquity since, declares Cato the Elder, the Romans owed to him to be able to do without doctors during six centuries. - could have fallen into oblivion at this point. This is because, as Dr J. Poucel wrote, "if man had not been devoured by his incurable itching to philosophize in the abstract, the old-fashioned use of natural methods would quickly have won its place. membership ”(p.241).
- the author presents the therapeutic properties of aloe, this plant known and used throughout the world, and the different preparation techniques it has developed and the drug obtained from this plant. He is embarking on a new therapy with biogenetic stimulators. It starts from the property of the plant which stimulates the tissues and renews them. In the use of the plant, the author is not satisfied with the methods of preparation known in traditional pharmacopoeia, but he uses biostimulant preparations taken by subcutaneous injection or oral application. A good number of diseases are treated by this new therapy.
- COVID-19 Coronavirus Deases-19
- COVID-19 is a viral infection that had just emerged towards the end of 2019, a virus characterized by its very rapid infectious force. The whole world is reached and is unarmed to fight it. Treatment protocols have been proposed, but they are far from beating the virus.
- the safest mode of fight consists of protective measures such as confinement, wearing a mask, washing the hands regularly with soap and water or with the gel. hydroalcoholic and distancing.
- the medicine is obtained from a mixture of essential oils of seven (7) medicinal plants.
- the particularity of the invention lies in the selection of the plants from which the essential oils are extracted, in the process for obtaining the medicament and its use.
- the essential oils of seven (7) plants are used in the composition of the drug. It is :
- the officinal lavender is a plant that grows in Europe, particularly in France, Italy, Spain and also in North Africa, as in Norway.
- the gasoline contains linalyl and geranyl ethers (35 to 55% linalyl acetate), geraniol, Iinalool ...
- the officinal lavender is well used in herbal medicine for its multiple therapeutic properties. Its essence is a pulmonary antiseptic; it is bactericidal, antispasmodic, anti-inflammatory, diuretic and tonic.
- the essential oil is applied, with success, in different pathologies. It is used alone in alcoholic solution. It can be applied to children. Antiviral and bactericidal, it is used against infectious diseases, diseases of the respiratory tract, such as asthma, heavy cough, influenza, bronchitis and tuberculosis. Its antiseptic power helps release bronchial secretions. She is used to fight gonorrhea due to its antiseptic properties, as well as leucorrhoea.
- the essential oil of lavender is not toxic and does not present any danger to the human body. It enters into the "vinegar of the four thieves", invented during the epidemic from 1628 to 1631, indoch.
- Ocimum basilicum produces an essential oil, composed of methyl chavicol also called estragol, which forms the main constituent, and it also contains monoterpenols such as linalool, terpineol, fenchol, eugenol.
- the essence is tonic, and is a very powerful antispasmodic. It is an intestinal antiseptic and an anti-inflammatory.
- the essential oil is used against rheumatoid arthritis for its anti-inflammatory properties. It fights neuritis, shingles and herpes, mixed with other essential oils such as Cupressus sempervirens, Ravensara aromatica and Thymus vulgaris. Tired intellectuals would consume it to regain their balance.
- the plant grows in the South of France, in Italy, Spain, Tunisia ...
- Parts used Essential oil obtained by steam distillation of flowering tops.
- the essential oil of rosemary is a general stimulant, equivalent to that of thyme; it is an antiseptic and fights bronchopulmonary pathologies; it is antispasmodic in combination with other essences. She treats gout; she is an emmenagogue (she regulates the cycle of women). It is diuretic and sudorific.
- Rosemary essential oil is prescribed for people with general asthenia and for people who suffer from memory loss. To women who suffer from dysmenorrhea, aromatic oil is applied. It effectively fights the affections of the nervous system, such as epilepsy and the sequelae of paralysis. There is a particular characteristic of aromatic oil to note: it enters into all the preparations of other oils in alcoholic solution and reinforces their synergy; it blends harmoniously with other oils.
- the essential oil of rosemary is not toxic; however, it should be noted that used in excessive amounts it is epileptic. Like thyme, it is part of the "vinegar of the 4 thieves", invented during the epidemic from 1628 to 1631 indoch.
- the cypress is the tree of cemeteries. It is recognized quite easily, thanks to its evergreen leaves, having a long pyramidal crown. It comes from the Mediterranean basin. Parts used: Essential oil, obtained by distillation of the fruits, called cypress nuts. The cypress has been used since ancient times by the Assyrians, a people who lived in present-day Iraq. Its essential oil contains a catechetical tannin, a terpene alcohol, cypress camphor. It pairs easily with other essences. Active ingredients: Cypress oil contains a lot of constituents; 180 are mentioned. It has monoterpene, sesquiternic and diterpene hydrocarbons.
- the essential oil of the cypress is vasoconstrictor and invigorating of the veins, antispasmodic and antirheumatic. It is a general rebalancing, especially of the nervous system.
- the essence oil treats and regulates ovarian disorders and those of menopause, is prescribed against spasmodic cough, influenza, enuresis (urinary incontinence). It is prescribed for venous circulatory disorders. For coughs, it is combined with the essence of thyme (thymol). It is applied in the case of nervous fatigue or exhaustion. It is combined with Rosmarinus officinalis, Mentha piperita to restore balance in diabetics and thus reduce insulin doses.
- FIFTH PLANT Pinus sylvestris Family: French conifers: Scots pine
- the wild pine is very widespread in the cold and high regions of Europe, in the Nordic countries. It is also cultivated in the plains. Parts used: essential oil from needles.
- Essential oil obtained by steam distillation of the needles. It contains an oil rich in pinene, sylvestrene, bornyl acetate.
- the essential oil of the Scots pine is used against diseases of the respiratory tract: colds, bronchitis, pneumonia, asthma, tuberculosis. It effectively fights urinary disorders, such as cystitis, lower prostatitis and infections in general. It is prescribed against gallstones.
- the essential oil contains monoterpenes, sesquiterpenes and monoterpenols.
- juniper extracted from the berries, is tonic for the visceral functions, the nervous system, the digestive tract and a general stimulant of the secretions.
- Depurative it is a pulmonary, digestive, urinary and blood antiseptic. It is an anti-rheumatic drug, promoting the excretion of uric acid and toxins, and is anti-diabetic.
- the essential oil is a prophylaxis against contagious diseases. It is prescribed in cases of hepato-pancreatic insufficiency in combination with Rosmarinus officinalis; it is used against diseases of the urinary tract (kidneys and bladder) and painful menstruation. It is involved in basic treatments for cancerous tumors. It is taken 5 to 10 drops per day, in alcoholic solution.
- Cajeput Melaleuca leucadendron is a tree that grows in the Philippines, Malaysia, Moluccas ...
- the essential oil is obtained by steam distillation of the leaves and buds.
- the gasoline contains cineol (60-75%) and left-hand pinene. There is another Melaleuca, the niaouli, which contains upright pinene. There is also terpineol.
- the essential oil is a general antiseptic against lung, intestinal and urinary tract infections. It is antispasmodic and antineuralgic.
- the product is composed of essential oils from seven plants, which can be obtained from pharmacies, herbalists or from a manufacturer.
- the preparation consists of mixing essential oils in alcohol at 90 ° or 95 °. This formula has the advantage that it allows the body to easily absorb the oils. There is no fear of any risk that comes from alcohol.
- the product obtained from the mixture of these seven essential oils has several therapeutic properties: it is antiviral, bactericidal, anti-inflammatory, antispasmodic, diuretic, tonic and cytophylactic. It is a powerful bronchopulmonary and intestinal antiseptic, a general stimulant, fights asthenia. It is an anti-infectious agent for the urinary tract. 3-C / USE
- This blend of essential oils, used alone, can treat COVID-19 and CORONAVIRUS illnesses in 12 days.
- This mixture of essential oils associated with the mixture of extracts of eight (8) plants composed of: Xylopia aethiopica, Allium sativum, Eugenia caryophyllata, Zingiber officinale, Myristica fragans, Citrus limonium, Aloes, Cymbopogon citratus allows the treatment of COVID- 19 and CORONAVIRUS infections within 7 days.
- This combination is also used against shingles and makes it disappear in 48 hours. It effectively fights lung diseases: bronchitis, tuberculosis, influenza, asthma, colds, coughing. It is also used for people suffering from urinary tract infections: gonorrhea, chlamydial infection, cystitis, leucorrhoea, dysmenorrhea. It is prescribed against rheumatic diseases. She is an emenagogue.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
OA1202000183 | 2020-05-26 | ||
PCT/OA2021/000002 WO2021242124A1 (fr) | 2020-05-26 | 2021-05-11 | Medicament a base d'un melange d'huiles essentielles de sept(7) plantes medicinales pour le traitement de la covid-19, utilise seul ou en association avec le melange d'extraits de huit (8) autres plantes medicinales |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4157303A1 true EP4157303A1 (fr) | 2023-04-05 |
Family
ID=76444521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21732604.0A Pending EP4157303A1 (fr) | 2020-05-26 | 2021-05-11 | Medicament a base d'un melange d'huiles essentielles de sept(7) plantes medicinales pour le traitement de la covid-19, utilise seul ou en association avec le melange d'extraits de huit (8) autres plantes medicinales |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP4157303A1 (fr) |
WO (1) | WO2021242124A1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060068044A1 (en) | 2004-09-30 | 2006-03-30 | Max Reynolds | Antimicrobial compositions and applications therefore |
FR2889909B1 (fr) * | 2005-08-29 | 2009-01-23 | Marco Pacchioni | Composition acarifuge et/ou acaricide a base d'huiles essentielles |
EP2878303B1 (fr) * | 2013-11-29 | 2017-11-15 | Doris Hefti | Composition pour l'aromathérapie, la médecine aromatique et l'aromatologie |
-
2021
- 2021-05-11 EP EP21732604.0A patent/EP4157303A1/fr active Pending
- 2021-05-11 WO PCT/OA2021/000002 patent/WO2021242124A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021242124A1 (fr) | 2021-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lawless | The Encyclopedia of essential oils: the complete guide to the use of aromatic oils in aromatherapy, herbalism, health, and well being | |
Lis-Balchin | Aromatherapy science: a guide for healthcare professionals | |
Elujoba et al. | Traditional medicine development for medical and dental primary health care delivery system in Africa. | |
Sellar | The directory of essential oils | |
Manganelli et al. | Ethnopharmacobotanical studies of the Tuscan Archipelago | |
Maqbool et al. | Herbal medicines as an alternative source of therapy: a review | |
Nomicos | Myrrh: medical marvel or myth of the magi? | |
Belhouala et al. | Medicinal plants used by traditional healers in Algeria: A multiregional ethnobotanical study | |
Tewari et al. | A review on phytoconstituents of Ocimum (Tulsi) | |
El Beyrouthy et al. | Ethnopharmacological survey of the indigenous Lamiaceae from Lebanon | |
US8821948B2 (en) | Therapeutic, bio-affecting and body treating composition | |
Stiles | The essential oils complete reference guide: Over 250 recipes for natural wholesome aromatherapy | |
WO2021242123A1 (fr) | Médicament à base d'extraits de huit (8) plantes médicinales pour le traitement de la covid-19 | |
Higley | Reference guide for essential oils | |
Dousti et al. | Evidence-based traditional persian medicine | |
EP4157303A1 (fr) | Medicament a base d'un melange d'huiles essentielles de sept(7) plantes medicinales pour le traitement de la covid-19, utilise seul ou en association avec le melange d'extraits de huit (8) autres plantes medicinales | |
Baudoux | Contemporary French Aromatherapy: A Pharmacological and Therapeutic Guide to 100 Essential Oils | |
Curtis et al. | Neal's Yard Remedies Essential Oils: Restore* Rebalance* Revitalize* Feel the Benefits* Enhance Natural Beauty* Create Blends | |
Curtis et al. | Essential Oils: All-natural remedies and recipes for your mind, body and home | |
Darrell | Essential Oils: A Concise Manual of Their Therapeutic use in Herbal and Aromatic Medicine | |
Obouayeba et al. | Ethnopharmacological study of medicinal plants sold in some markets in Haut-Sassandra (Central-West, Côte d’Ivoire) | |
Johnson | Ethnobotony, the leaves of life | |
Fite et al. | Essential Oils for Healing: Over 400 All-Natural Recipes for Everyday Ailments | |
Gould | Aromatherapy for holistic therapists | |
Higley | Quick reference guide for using essential oils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20221108 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |